Imjectt) CBSA Immune Modulator

SECTION 2: Hazards identification

(29 CFR 1910.1200) Emerd ency OVeVIEW Physical state + Solid. [Lyophilized powder ] Color + White. Odor » Odorless,

Signal word

» WARNING!

Hazard statements

» CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION, CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. Precautionary meastires —: Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Wash thoroughly after handling,

Potential Acute Health Effects

Inhalation - Irritating to respiratory system. Ingestion No known significant effects or critical hazards. Skin ‘Irritating to skin. TAS2011, wh Le Scere Research FO Bex 117 Recelond. L (85 wwe loerme.cem, Pierce Beleeclogy Ie. 3747 N Meridia Road GI1E i Imject® cBSA Immune Modulator Eyes Irritating to eyes. Carcinogenicity + No known significant effects or critical hazards.

Potential chronic health

Contains material that may cause target organ damage, based on animal data, Mutagenicity No known significant effects or critical hazards.

Teratogenic Effects

No known significant effects or critical hazards. Developmental effects + No known significant effects or critical hazards, Fertility effects + No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: skin, eyes, stomach, Over-exposure siqnsisymptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data, Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this MSDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure See toxicological information (Section 11)